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OBJECTIVE: We aimed to investigate whether the elevated risk of gastric cancer among patients with gastric 
ulcer (GU) and the enigmatic low risk among patients with duodenal ulcer (DU) pertain to both cardia 
and noncardia cancer. We also studied the risks among operated patients while taking the disparate 
baseline risks into consideration. 
METHODS: Retrospective cohorts of 59,550 and 79,412 unoperated patients with DU and GU, respectively, plus 
12,840 patients with partial gastric resection and 8,105 with vagotomy, recorded in the Swedish 
Inpatient Register since 1970, were followed from the ﬁrst hospitalization (date of operation for the 
surgery cohort) until occurrence of any cancer, death, emigration, deﬁnitive surgery, or December 31, 
2003. Standardized incidence ratios (SIRs) with 95% conﬁdence intervals (CIs) expressed relative 
risk (RR), compared to the age-, sex-, and calendar period-matched Swedish population. Cox 
regression produced adjusted RR estimates among operated patients, relative to unoperated ones 
with the same ulcer type. 
RESULTS: While unoperated DU patients had a halved risk of noncardia cancer (SIR = 0.5, 95% CI 0.4–0.7), 
their risk of cardia cancer was slightly above expectation (SIR = 1.2, 95% CI 0.8–1.7). Unoperated 
GU patients had doubled risks for both cancers (SIR = 2.1, 95% CI 2.0–2.4 and SIR = 1.9, 95% 
CI 1.4–2.3, respectively). DU patients who underwent gastric resection had a 60% risk elevation (RR 
= 1.6, 95% CI 1.0–2.5) compared to unoperated ones. Vagotomy was associated with a greater risk 
in the ﬁrst 10 yr, but this excess disappeared with further follow-up. Resected GU patients had a 40% 
risk reduction relative to their unoperated peers (RR = 0.6, 95% CI 0.5–0.8). This reduction persisted 
well beyond the ﬁrst postoperative decade. 
CONCLUSION: The DU-related protection against gastric cancer does not seem to pertain to cardia cancer. With 
gastric resection, risks are shifted toward normality, regardless of underlying ulcer type. 
(Am J Gastroenterol 2007;102:1185–1191) 
INTRODUCTION 
Helicobacter pylori (H. pylori) is a well-established cause of 
peptic ulcer disease (1, 2). It appears that the clinical outcome 
of the infection is linked to the pattern of colonization; those 
with an antrum-predominant infection tend to have less efﬁ­
cient control of acid production, leading to hyperacidity (3), 
and the development of duodenal ulcer (DU) in some (4). In 
contrast, H. pylori colonizes both the antrum and corpus in 
other hosts. Corpus-predominant gastritis, further inhibition 
of acid secretion from the corpus parietal cells, and gastric 
ulcer (GU) formation tend to follow down the line. 
We have previously reported that while patients hospital­
ized for GU, as expected, have a greater risk of gastric cancer, 
those with DU have a low risk (5), despite the strong over­
all association between H. pylori seropositivity and noncar­
dia gastric cancer risk (6–9), and the fact that approximately 
90% of duodenal ulcer patients are infected. This observa­
tion points to the possibility of important effect modiﬁcation 
of the H. pylori–gastric cancer relationship, conceivably by 
speciﬁc strain characteristics, host predisposition, external 
or intragastric environment, or any combination of these fac­
tors. Due to limited sample size and relatively short follow-
up, analyses by anatomic subsite of stomach cancer were not 
possible in our previous study. Moreover, since artiﬁcially 
induced hypoacidity could theoretically be conducive to 
H. pylori colonization of the gastric corpus—in turn a con­
ceivable risk factor for noncardia gastric cancer—studies 
of the long-term outcome among vagotomized patients are 
clearly warranted. 
In this large retrospective cohort study, we have expanded 
our previous cohort (5) and extended follow-up considerably, 
thus permitting a thorough exploration of gastric cancer risk 
by anatomical subsite among unoperated patients hospital­
ized for DU or GU. Furthermore, although studied previously 
(10–19), owing to the accumulation of person-time among 
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operated patients, this study offers an unprecedented oppor­
tunity to study gastric cancer risk with reasonable precision 
among vagotomized patients and those who underwent par­
tial gastric resection while taking the disparate baseline risks 
into consideration. 
MATERIAL AND METHODS 
The Cohort 
The methodology used in this register-based retrospective 
cohort study has been detailed previously (5). Brieﬂy, all pa­
tients in the Swedish Inpatient Register (20) with a diagnosis 
of DU (International Classiﬁcation of Disease [ICD-7] code 
541, ICD-8 and ICD-9 code 532, and ICD-10 code K26) 
or GU (ICD-7 code 540, ICD-8 and ICD-9 code 531, and 
ICD-10 code K25) were considered for inclusion in the co­
hort. We did not include individuals who were registered with 
both types of ulcer. For each potential subject, we identiﬁed 
the index episode—the ﬁrst recorded hospitalization for the 
ulcer. 
For each of the potentially eligible subjects, the national 
registration number (NRN, individually unique personal 
identiﬁers assigned to all Swedish residents and used in all of 
the registries used in this study) was checked in nationwide 
registers of total population, emigration, and death. Records 
with NRNs that could not be located in any of these registers 
(N = 4,536) were regarded as invalid and excluded. We fur­
ther excluded 22,851 patients with diagnoses of any cancer 
before or at the time of the index episode, 12,232 individuals 
who died during the index hospitalization, and 1,912 records 
due to inconsistencies revealed during data editing and record 
linkages. Finally, our study included 176,017 individuals for 
further analysis. 
Follow-Up 
We linked the national registration numbers to the nation­
wide registries of migration and cause of death to obtain 
information on dates of emigration and death. The national 
Swedish Cancer Registry, established in 1958 and reportedly 
more than 98% complete (21), was used to identify all can­
cer cases in the cohort. We only considered ﬁrst cancers and 
disregarded benign tumors or cancers found incidentally at 
autopsy. The patients in the unoperated cohort were followed 
up from the date of their ﬁrst hospital admission for DU or GU 
until the date of emigration, death, gastric resection, vago­
tomy, a diagnosis of any cancer, or until December 31, 2003, 
whichever occurred ﬁrst. However, person-time accrued and 
cancer events observed during the ﬁrst year of follow-up was 
not counted in the analyses, since prodromal cancer symp­
toms are likely to increase the probability of hospitalization 
for any known prevalent disease, including peptic ulcer, lead­
ing to selection bias in the ﬁrst year. Further, cancers that are 
mistaken for benign ulcers will artiﬁcially inﬂuence the can­
cer rates in the ﬁrst year. 
Patients who underwent gastric resection or vagotomy for 
peptic ulcer were also followed from the time of surgery un­
til the date of emigration, death, a diagnosis of any cancer, 
any subsequent gastric surgery, or until December 31, 2003, 
whichever occurred ﬁrst. 
Statistical Analysis 
The standardized incidence ratio (SIR)—the ratio of the ob­
served to the expected number of cancers in the cohort—was 
used as a measure of relative risk (RR). The expected num­
ber of cancers was calculated by adding up all person-time 
experienced in the cohort divided into strata of sex, age (in 
5-yr groups), and calendar year of observation (aggregated 
into 5-yr intervals) and then multiplying the stratum-speciﬁc 
person-time by the corresponding stratum-speciﬁc incidence 
rates obtained in the entire Swedish population. In the cal­
culation of these incidence rates, the denominator was esti­
mated by the number of mid-year population without a previ­
ously reported cancer. The 95% conﬁdence intervals (CIs) for 
the SIRs were calculated assuming that the observed events 
followed a Poisson distribution (22). We further performed 
stratiﬁed analyses by follow-up duration, sex, presence of 
complications (bleeding or perforation) at the time of hospi­
talization, calendar period of index hospitalization (before vs 
after 1980), age at entry (<50, 50–69, 70+), and the calendar 
period of follow-up (before vs after 1990). 
To explore the effects of gastric resection and vagotomy 
on the risk of gastric cancer among DU or GU patients, we 
made internal comparisons between the various subcohorts. 
We ﬁrst split the data by the type of surgical treatment, if any, 
and follow-up time after surgery (≤10 yr vs >10 yr), then 
calculated RRs using multivariate Cox proportional hazards 
regression assuming multiplicative effects between explana­
tory variables and outcome (gastric cancer). Attained age (un­
derlying time scale) and sex were included in the regression 
models. 
All statistical analyses were performed with SAS, release 
8.2 (SAS Institute, Cary, NC); PROC PHREG was used for 
the regression model. All statistical tests were 2-sided. 
RESULTS 
The ﬁnal cohort included 59,550 unoperated patients with DU 
(64.2% male), 79,412 unoperated patients with GU (52.3% 
male), 12,840 patients with partial gastric resection (59.0% 
male), and 8,105 patients with vagotomy (69.8% male). Pa­
tients who underwent surgical treatment were younger than 
unoperated patients and followed for longer time. About half 
of the peptic ulcer patients were hospitalized due to bleeding 
and about 10% due to perforation. Some characteristics of 
the patients are given in Table 1. 
Duodenal Ulcers 
Among the 59,550 unoperated patients with DU followed for 
an average of 8.8 yr, 36 cardia cancer cases were diagnosed 
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Table 1. Characteristics of Patients Hospitalized for Peptic Ulcer in Sweden 1970–2003 
Gastric Partial Gastric Resection 
Vagotomy Characteristic Duodenal Ulcers Ulcers Billroth I Billroth II All 
Number of patients 
Male (%) 
Age at index hospitalization, (%) 
<40 yr 
40–49 yr 
50–59 yr 
60–69 yr 
70–79 yr 
≥80 yr 
Mean (yr) 
Reason for index hospitalization, (%) 
Bleeding 
Perforation 
Other 
Total person-year of follow-up 
Average follow-up time, yr 
Mean age at cancer diagnosis, yr 
Gastric cardia cancer 
Gastric noncardia cancer 
59,550 
64.2 
11.8 
11.7 
15.9 
19.8 
24.3 
16.5 
62.4 
49 
9 
42 
494,577 
8.8 
69 
73 
79,412 
52.3 
6.1 
8.3 
14.1 
20.3 
29.2 
22.0 
66.9 
47 
9 
44 
552,736 
7.0 
74 
73 
6,639 
49.3 
12.7 
20.2 
28.0 
23.7 
13.2 
2.3 
55.3 
38 
6 
56 
105,935 
16 
68 
70 
5,407 
71.4 
10.7 
16.1 
26.1 
25.7 
17.7 
3.8 
57.7 
51 
10 
39 
74,856 
14 
70 
69 
12,840 
59.0 
11.6 
17.9 
26.8 
24.7 
15.7 
3.4 
56.7 
44 
9 
47 
189,777 
14.9 
69 
69 
8,105 
69.8 
29.0 
25.2 
24.2 
13.3 
6.4 
1.9 
48.4 
32 
6 
62 
138,814 
17.3 
70 
65 
after the ﬁrst year of follow-up (SIR = 1.2, 95% CI 0.8–1.7) 
(Table 2). Stratiﬁed analyses of SIR for cardia cancer were 
essentially uninformative due to small numbers of observed 
cases in substrata. Noncardia gastric cancer was diagnosed 
less often than expected (N = 94, SIR = 0.5, 95% CI 0.4–0.7). 
The low RR was seen in virtually all investigated substrata, 
but it appeared to be more marked among men than among 
women, where the point estimate was no more than 20% 
below unity and nonsigniﬁcant (Table 2). 
Gastric Ulcers 
Following 79,412 unoperated patients with GU for an av­
erage of 7.0 yr, a higher than expected incidence of gastric 
cardia cancer emerged (N = 65, SIR = 1.9, 95% CI 1.4–2.3) 
(Table 3). No conspicuous variation in RR of cardia cancer 
was observed in stratiﬁed analyses by follow-up duration, 
sex, complication history, calendar year, or age at entry, al­
though only one case was observed among patients less than 
50 yr of age. During the same follow-up, 462 noncardia gas­
tric cancers were registered (SIR = 2.1, 95% CI 2.0–2.4). The 
relative excess tended to be higher among patients entering 
the cohort in the early part of the study period, and among 
those who belonged to the younger age strata at entry. 
Surgical Treatment 
Table 4 shows the adjusted RRs (hazards) of developing non­
cardia cancer among operated ulcer patients, relative to un­
operated patients with the same ulcer type (internal com­
parison). These RRs were estimated with Cox proportional 
hazards regression modeling. For comparison, SIR values, 
i.e., the RRs in each subcategory relative to the age-, sex-, 
and calendar period-matched general population, are shown 
in the rightmost column. The results for cardia cancer were 
essentially uninformative due to small numbers of observed 
cases in the exposed groups. For the same reason, we do 
not report RRs of noncardia cancer among vagotomized GU 
patients. 
Overall, operated patients with DU remained at a risk of 
noncardia gastric cancer that was below the risk in the match­
ing general population (SIR = 0.8, 95% CI 0.5–1.2 among 
partially resected and SIR = 0.8, 95% CI 0.5–1.3 among 
Table 2. Standardized Incidence Ratios (SIRs) and Their 95% Con­
ﬁdence Intervals (CIs) for Gastric Cancer by Subsite Among Non-
operated Patients With Duodenal Ulcer, by Follow-Up Duration, 
Sex, Presence of Complication, and Calendar Year of Index Hospi­
talization∗ 
Cardia Cancer Noncardia Cancer 
No. of 
Cases SIR (95% CI) 
No. of SIR 
Cases (95% CI) 
Overall 36 1.2 (0.8–1.7) 
Follow-up year 
2–10 27 1.4 (0.95–2.1) 
11+ 9 0.8 (0.4–1.5) 
Sex 
Men 32 1.3 (0.9–1.8) 
Women 4 0.9 (0.3–2.4) 
 Complication†
Yes 20 1.0 (0.6–1.6) 
No 16 1.5 (0.9–2.4) 
Calendar year of index hospitalization 
1970–1979 6 0.6 (0.2–1.3) 
1980–2003 30 1.5 (1.01–2.1) 
Age at entry 
<50 7 1.8 (0.7–3.7) 
50–69 20 1.3 (0.8–2.0) 
70+ 9 0.8 (0.4–1.6) 
Calendar year of follow-up 
<1990 8 0.9 (0.4–1.9) 
≥1990 28 1.3 (0.9–1.9) 
94 
70 
24 
61 
33 
60 
34 
45 
49 
13 
41 
40 
48 
46 
0.5 (0.4–0.7) 
0.6 (0.5–0.7) 
0.5 (0.3–0.7) 
0.5 (0.4–0.6) 
0.8 (0.5–1.1) 
0.5 (0.4–0.7) 
0.6 (0.4–0.8) 
0.6 (0.5–0.8) 
0.5 (0.4–0.7) 
1.0 (0.5–1.7) 
0.5 (0.4–0.7) 
0.5 (0.4–0.7) 
0.6 (0.5–0.8) 
0.5 (0.4–0.7) 
∗First year of follow-up excluded. 
†Including bleeding and perforation. 
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Table 3. Standardized Incidence Ratios (SIRs) and Their 95% Con­
ﬁdence Intervals (CIs) for Gastric Cancer by Subsite Among Non-
operated Patients With Gastric Ulcer, by Follow-Up Duration, Sex, 
Presence of Complication, and Calendar Year of Index Hospitaliza­
tion∗ 
Cardia Cancer Noncardia Cancer 
No. of SIR 
Cases (95% CI) 
No. of SIR 
Cases (95% CI) 
Overall 65 1.9 (1.5–2.5) 
Follow-up year 
2–10 49 2.1 (1.6–2.8) 
11+ 16 1.6 (0.9–2.5) 
Sex 
Men 52 2.0 (1.5–2.6) 
Women 13 1.7 (0.9–2.9) 
 Complication†
Yes 39 1.9 (1.4–2.6) 
No 26 2.0 (1.3–2.9) 
Calendar year of index hospitalization 
1970–1979 21 2.2 (1.4–3.4) 
1980–2003 44 1.8 (1.3–2.5) 
Age at entry 
<50 1 0.4 (0.01–2.0) 
50–69 40 2.5 (1.8–3.4) 
70+ 24 1.6 (1.1–2.5) 
Calendar year of follow-up 
<1990 26 2.6 (1.7–3.8) 
≥1990 39 1.7 (1.2–2.3) 
462 
350 
112 
284 
178 
284 
178 
200 
262 
54 
204 
204 
237 
225 
2.1 (2.0–2.4) 
2.2 (1.9–2.4) 
2.1 (1.7–2.5) 
2.1 (1.8–2.3) 
2.3 (2.0–2.6) 
2.2 (2.0–2.4) 
2.1 (1.8–2.4) 
2.4 (2.1–2.8) 
2.0 (1.8–2.2) 
5.4 (4.1–7.1) 
2.3 (2.0–2.6) 
1.8 (1.5–2.0) 
2.3 (2.1–2.7) 
2.0 (1.7–2.2) 
∗First year of follow-up excluded. 
†Including bleeding and perforation. 
vagotomized patients, Table 4), but the risk deﬁcit was less 
than among unoperated DU patients and statistically non-
signiﬁcant. When operated DU patients were directly com­
pared with unoperated ones, a statistically signiﬁcant 60% 
risk elevation was unveiled among those who had undergone 
gastric resection and there was a tendency toward increas­
ing risk with longer follow-up. A statistically nonsigniﬁcant 
30% increase in risk of noncardia cancers was noted also 
among those who had been subjected to vagotomy, but it ap­
peared as if the excess was conﬁned to the ﬁrst 10 yr after 
the operation. 
As opposed to unoperated GU patients, whose risk of non­
cardia gastric cancer was more than twofold higher than in the 
matching general population, GU patients with a history of 
gastric resection had a SIR only slightly above unity (Table 4). 
In a direct comparison between operated and unoperated GU 
patients, the former had a statistically signiﬁcant 40% risk re­
duction relative to the latter. This risk reduction was slightly 
smaller when more than 10 yr had elapsed after the oper­
ation, and with the matching general population as refer­
ence, the SIR rose to 1.5 and became again statistically signi­
ﬁcant. 
DISCUSSION 
This large register-based retrospective cohort study with es­
sentially complete and unbiased long-term follow-up persua-
Table 4. The Relative Risks (RRs) of Noncardia Gastric Cancer 
Among Operated Ulcer Patients, Relative to Unoperated Ones With 
the Same Ulcer Type 
No. 
of Cases 
Noncardia Cancer 
Internal External 
Comparison Comparison 
RR (95% CI)∗ SIR (95% CI) 
Duodenal ulcer partial resection 
Not operated 94 
Operated overall 23 
Year 2–10 of follow-up 8 
Year 11+ of follow-up 15 
Vagotomy 
Not operated 94 
Operated overall 21 
Year 2–10 of follow-up 14 
Year 11+ of follow-up 7 
Gastric ulcer partial resection 
Not operated 462 
Operated overall 53 
Year 2–10 of follow-up 27 
Year 11+ of follow-up 26 
Reference 
1.6 (1.0–2.5) 
1.3 (0.6–2.7) 
1.7 (1.0–3.0) 
Reference 
1.3 (0.8–2.1) 
2.0 (1.1–3.7) 
0.8 (0.4–1.7) 
Reference 
0.6 (0.5–0.8) 
0.6 (0.4–0.9) 
0.7 (0.5–1.0) 
0.5 (0.4–0.7) 
0.8 (0.5–1.2) 
0.6 (0.3–1.2) 
1.0 (0.6–1.6) 
0.5 (0.4–0.7) 
0.8 (0.5–1.3) 
1.2 (0.7–2.1) 
0.5 (0.2–1.1) 
2.1 (2.0–2.4) 
1.2 (0.9–1.6) 
1.0 (0.7–1.5) 
1.5 (1.0–2.1) 
These internal comparisons were made with Cox proportional hazard modeling,
 
adjusted for attained age- and sex-. As a measure of RR in the respective subcategories
 
relative to the age-, sex-, and calendar period-matched general population (external
 
comparison), SIR values are given in the rightmost column. The ﬁrst year of follow-up
 
is excluded in all analyses.
 
∗Relative risk and 95% conﬁdence interval.
 
sively conﬁrms the divergence between duodenal and gastric 
ulcer in their relationships with gastric cancer (5); with a con­
siderably longer maximum follow-up time, there were no in­
dications that the enigmatic low risk of gastric cancer among 
DU patients will ultimately return to the same level as in the 
age-, sex-, and calendar period-matched general population. 
Nor were there any clear signs that the doubled risk among 
GU patients will eventually wear off. The present analysis 
revealed that the low risk among DU patients pertained only 
to noncardia gastric cancer and not to cardia cancer. The 
risk elevation among GU patients, on the other hand, was 
seen for both cancer sites. Another new addition to current 
knowledge is that partial resection in DU patients, despite 
the obvious reduction in tissue at risk, was associated with 
a signiﬁcant increase in risk of noncardia gastric cancer if 
these patients were compared with unoperated patients with 
DU. Because the baseline risk among the latter is so low, op­
erated patients still had a risk that was lower than that in the 
general population. Gastric resection in GU patients, on the 
other hand, was linked to signiﬁcant risk reductions relative 
to unoperated patients; in comparison with the general pop­
ulation, their risk of noncardia gastric cancer was brought 
down to normal—at least within the ﬁrst 10 yr after the op­
eration. Further, vagotomized DU patients had a greater risk 
of noncardia gastric cancer in the ﬁrst decade after the op­
eration when compared with unoperated patients with the 
same disease, but this excess disappeared when 10 yr had 
elapsed. 
The reduction in risk for gastric cancer among DU 
patients—despite the strong links between DU and H. pylori 
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infection and between H. pylori and gastric cancer—is al­
ready well established (5, 9, 23) and the mechanisms will not 
be further discussed herein. It is noteworthy, though, that the 
apparent protection conferred by DU-related factors seemed 
not to affect the cardia region. This ﬁnding, however, is at 
odds with two previous studies (23, 24), which reported an 
inverse relationship also with cardia cancer. These studies, 
one a case–control analysis within a register of patients at 
hospitals of the US Department of Veterans Affairs (23), the 
other a hospital-based case–control study from Taiwan with 
self-reported ulcer histories (24), both used mixed hospital 
populations as reference, and left truncation and/or unregis­
tered ulcer diagnoses may have affected the American results. 
What was classiﬁed as cardia cancer may also have differed 
between the countries. If it is assumed that the DU-related 
“protection” against gastric cancer is in some way depen­
dent on the interaction between H. pylori and the host, then 
our ﬁnding appears more plausible since the relationship be­
tween H. pylori infection and cardia cancer seems to be weak 
or nonexisting (25). This issue, however, must still be con­
sidered unresolved. 
The positive association between GU and cardia cancer 
risk was more in line with the previous studies; the Taiwanese 
study found a twofold, albeit statistically nonsigniﬁcant, risk 
elevation (24), while the American VA study saw no associ­
ation (23). Whereas the mechanisms by which DU might 
confer protection against cardia cancer remain obscure, a 
positive association between GU and this cancer may be 
expected given the hypothesized special importance of N­
nitroso compounds in the etiology of cardia cancer (26) and 
the documented increase in nitrite and N-nitrosamine levels 
in the stomachs of patients with GU and/or hypochlorhydria 
(27, 28). 
Numerous studies in the past have addressed gastric can­
cer risk among patients who have undergone partial gastric 
resection for peptic ulcer, but the results have not been all con­
sistent (29, 30). In fact, the results range from a more than 
twofold greater to an 80% lower risk (29). More recently, it 
was realized that both underlying disease and time since op­
eration are important, and that the risk among DU patients 
is below expectation for some 20 yr, ostensibly due to the 
reduction of tissue at risk, until it starts to rise (29). To our 
knowledge, no previous study has compared operated with 
unoperated patients with the same type of ulcer disease and 
followed them for prolonged periods. Somewhat surprisingly, 
surgically resected DU patients had a greater risk, which in 
stratiﬁed analyses was never below that observed among the 
unoperated ones (although only 30% higher and statistically 
nonsigniﬁcant in the ﬁrst decade), despite the removal of a 
substantial part of the organ. However, the risk was never 
higher than that in the matching general population. This 
was contrary to the ﬁndings among resected GU patients, 
whose risk was below that among unoperated GU patients 
for the entire observation period. Because of the high base­
line risk among patients with unoperated GU, the risk among 
operated GU patients never fell below that in the matching 
general population. With the exception of the close to nor­
mal risk relative to the general population among operated 
GU patients, our ﬁndings are consistent with current views 
in the stump cancer literature but they also shed light on the 
reasons for the discrepancies between the earlier reports. The 
reason why resection in GU disease seemingly—and at least 
temporarily—reduces gastric cancer risk, while the same re­
section rather seems to already increase the risk within the 
ﬁrst decade in DU patients, is unclear. One could speculate 
that premalignant foci are already common in GU patients so 
that removal of tissue will have an almost immediate effect. It 
is even conceivable that a non-negligible number of misdiag­
nosed malignant gastric ulcers remain silent for several years 
and thus contribute substantially to the greater gastric cancer 
incidence among unoperated GU patients. As no malignant 
or premalignant foci are expected to be present among DU 
patients who undergo resection, removal of tissue may not 
have any noticeable effect in the ﬁrst decades. Why the risk 
among resected DU patients is slightly higher than among 
the unoperated still begs an answer. Clearly, chance could 
be one explanation for our ﬁndings. The possibility of con­
founding by indication must also be entertained, particularly 
as the excess risk was already noticeable in the ﬁrst decade 
after the operation. Operated patients, no doubt, have, on 
average, more severe disease than the unoperated, but if it 
is accepted that DU protects against noncardia gastric can­
cer, it seems counterintuitive to assume that those with more 
severe disease should have a higher cancer risk. Factors con­
tributing to complications—in turn prompting the decision to 
operate—should be considered; NSAID use is such a factor, 
but since it is protective (31), the effect of this confound­
ing is expected to be an even lower risk among operated 
patients. Smoking may also be such factor, and it is clearly 
a risk factor for gastric cancer (32). We had no information 
about smoking habits among our patients, so it is unclear if 
smokers are enriched among those who undergo surgery. If 
confounding would be the sole explanation for the difference 
in risk between operated and unoperated patients, the reason 
for the differential effects in DU and GU would still need to 
be explained. 
We found a signiﬁcantly greater risk for noncardia gastric 
cancer among DU patients who underwent vagotomy, com­
pared with unoperated DU patients, but only during the ﬁrst 
10 yr after the operation. Greater risks have been reported 
previously (11, 33, 34), and in a previous analysis of parts 
of the present cohort, followed up until 1988, we found a 
statistically nonsigniﬁcant SIR of 1.3. Although it is tempt­
ing to hypothesize that the change in gastric acidity might be 
conducive to intragastric N-nitrosation and subsequent gas­
tric cancer development, it would probably take many years 
before a clinically evident cancer would be diagnosed, and 
one would expect that the risk would increase gradually with 
follow-up time well beyond the ﬁrst decade. Therefore, con­
founding by factors related to the indication for surgery, for 
instance smoking, must be considered to be the most likely 
explanation for our ﬁnding. 
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Strengths of this study include the cohort design, the large 
sample size, and the essentially complete follow-up with in­
cidence as outcome. We also restricted the analysis to “clean” 
cases of duodenal and gastric ulcer; all patients who had both 
types of ulcer or who at any point in time switched between 
the categories were not included. As we had reasonably valid 
information about both diagnosis and procedure—in vali­
dation studies conducted in the Swedish Inpatient Register 
in 1986 and 1990 errors (stringent criteria) in the diagnos­
tic data were suspected in 17.3 and 14.2% of the records, 
while erroneous or missing procedure codes were noted in 
9.6%, almost half of which were for minor semi-invasive or 
auxiliary procedures combined with correctly recorded main 
procedures (35)—it was possible to compare operated pa­
tients with unoperated patients and thus to study the effect 
of surgery independent of the effects of the underlying dis­
ease. The restriction to in-hospital patients could be seen as a 
strength since in-hospital care will likely ensure a somewhat 
more rigorous disease classiﬁcation compared with outpa­
tient care. The validity of the outcome data was excellent; 
the completeness of the Swedish Cancer Register vis-a`-vis 
gastric cancer is 98% and the false-positive rate is 4% (36). 
However, the coding of site within the stomach is less trust­
worthy; the completeness of cardia cancer registration was 
only 69% and the positive predictive value for cardia cancer 
was 82% in a relatively recent validation study (36). Other 
caveats worth highlighting include the fact that hospitalized 
ulcer patients only represent a selected part of the entire pool 
of ulcer disease in the population; such patients are likely to 
be sicker, have more complications, have more comorbidity, 
and to generally have a less healthy lifestyle, compared with 
patients seen on an outpatient basis. Therefore, generaliza­
tions of the reported effect sizes must be done with caution. 
More importantly, we did not have information about a num­
ber of possible confounding factors such as smoking, diet, 
and drug use, as discussed above. Nor did we have infor­
mation about possible special indications for surgery such as 
failure to comply with pharmacological treatment, intractable 
pain, nutritional problems, and/or weight loss. Another lim­
itation lies in the fact that there was left truncation before 
the start of the inpatient registration. Some of our unoperated 
patients who entered the cohort in the early part of the study 
period could well have been operated on before they came 
into view in the register. Such misclassiﬁcation will tend to 
attenuate differences between operated and unoperated pa­
tients. Lastly, since peptic ulcer has been fairly common in 
the general population, SIRs may have been generally some­
what biased toward the null. As H. pylori eradication became 
ﬁrst-line treatment for peptic ulcer in the mid 1990s, we em­
ployed stratiﬁed analyses by follow-up time (before vs after 
year 1990) to explore if the risks diverged, but we did not ﬁnd 
any signiﬁcant difference, suggesting that eradication therapy 
has not importantly affected the observed associations. 
In conclusion, while GU patients have a greater risk for 
both cardia and noncardia gastric cancer, DU patients have a 
reduced risk only for noncardia cancer. Although the mecha­
nisms behind the differential relationships between duodenal 
ulcer disease and gastric cancer of the cardia and noncardia 
location remains unknown, an analogous differential asso­
ciation between H. pylori infection and these two types of 
cancer suggests that the underlying H. pylori infection might 
also play a pivotal role for the protection. Partial gastric re­
section seems to add to the risk among DU patients but to 
reduce risk among those with GU, at least in the ﬁrst 10–20 
yr. While this may suggest that removal of the distal stom­
ach also removes the cause for the differential association of 
duodenal and gastric ulcer disease, respectively, with gastric 
cancer risk, confounding by smoking may have contributed to 
the risk elevation among operated DU patients. Why similar 
confounding does not seem to have affected the risk among 
operated GU patients remains an unresolved enigma. 
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